These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Monitoring binding of HIV-1 capsid assembly inhibitors using (19)F ligand-and (15)N protein-based NMR and X-ray crystallography: early hit validation of a benzodiazepine series. Goudreau N; Coulombe R; Faucher AM; Grand-Maître C; Lacoste JE; Lemke CT; Malenfant E; Bousquet Y; Fader L; Simoneau B; Mercier JF; Titolo S; Mason SW ChemMedChem; 2013 Mar; 8(3):405-14. PubMed ID: 23401268 [TBL] [Abstract][Full Text] [Related]
4. The HIV-1 capsid protein as a drug target: recent advances and future prospects. Domenech R; Neira JL Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Lamorte L; Titolo S; Lemke CT; Goudreau N; Mercier JF; Wardrop E; Shah VB; von Schwedler UK; Langelier C; Banik SS; Aiken C; Sundquist WI; Mason SW Antimicrob Agents Chemother; 2013 Oct; 57(10):4622-31. PubMed ID: 23817385 [TBL] [Abstract][Full Text] [Related]
6. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication. Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656 [TBL] [Abstract][Full Text] [Related]
7. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly. Neira JL FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045 [TBL] [Abstract][Full Text] [Related]
8. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors. Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981 [TBL] [Abstract][Full Text] [Related]
9. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors. Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396 [TBL] [Abstract][Full Text] [Related]
10. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. Kelly BN; Kyere S; Kinde I; Tang C; Howard BR; Robinson H; Sundquist WI; Summers MF; Hill CP J Mol Biol; 2007 Oct; 373(2):355-66. PubMed ID: 17826792 [TBL] [Abstract][Full Text] [Related]
11. HIV capsid is a tractable target for small molecule therapeutic intervention. Blair WS; Pickford C; Irving SL; Brown DG; Anderson M; Bazin R; Cao J; Ciaramella G; Isaacson J; Jackson L; Hunt R; Kjerrstrom A; Nieman JA; Patick AK; Perros M; Scott AD; Whitby K; Wu H; Butler SL PLoS Pathog; 2010 Dec; 6(12):e1001220. PubMed ID: 21170360 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach. Romashov LV; Ananikov VP Org Biomol Chem; 2016 Dec; 14(45):10593-10598. PubMed ID: 27714265 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities. Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of an antiviral ankyrin targeting the HIV-1 capsid and molecular modeling of the ankyrin-capsid complex. Praditwongwan W; Chuankhayan P; Saoin S; Wisitponchai T; Lee VS; Nangola S; Hong SS; Minard P; Boulanger P; Chen CJ; Tayapiwatana C J Comput Aided Mol Des; 2014 Aug; 28(8):869-84. PubMed ID: 24997121 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699 [TBL] [Abstract][Full Text] [Related]
16. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment. Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719 [TBL] [Abstract][Full Text] [Related]
18. Fragment screening and HIV therapeutics. Bauman JD; Patel D; Arnold E Top Curr Chem; 2012; 317():181-200. PubMed ID: 21972022 [TBL] [Abstract][Full Text] [Related]
19. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity. Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621 [TBL] [Abstract][Full Text] [Related]
20. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer. Xu JP; Branson JD; Lawrence R; Cocklin S Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]